Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study

Jennifer C.E. Lane, James Weaver, Kristin Kostka, Talita Duarte-Salles, Maria Tereza F. Abrahao, Heba Alghoul, Osaid Alser, Thamir M Alshammari, Carlos Areia, Patricia Biedermann, View ORCID ProfileJuan M. Banda, Edward Burn, Paula Casajust, Kristina Fišer, Jill Hardin, Laura Hester, George Hripcsak, Benjamin Skov Kaas-Hansen, Sajan Khosla, View ORCID ProfileSpyros Kolovos, Kristine E. Lynch, Rupa Makadia, Paras P. Mehta, Daniel R. Morales, Henry Morgan-Stewart, Mees Mosseveld, Danielle Newby, Fredrik Nyberg, Anna Ostropolets, Rae Woong Park, View ORCID ProfileAlbert Prats-Uribe, Gowtham A. Rao, Christian Reich, Peter Rijnbeek, Anthony G. Sena, Azza Shoaibi, Matthew Spotnitz, Vignesh Subbian, Marc A. Suchard, David Vizcaya, Haini Wen, Marcel de Wilde, Junqing Xie, Seng Chan You, View ORCID ProfileLin Zhang, Simon Lovestone, Patrick Ryan, View ORCID ProfileDaniel Prieto-Alhambra on behalf of OHDSI-COVID-19 consortium
doi: https://doi.org/10.1101/2020.07.17.20156059
Jennifer C.E. Lane
1Centre for Statistics in Medicine. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Weaver
2Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ, USA 08560
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Kostka
3Real World Solutions, IQVIA, 201 Broadway # 5, Cambridge, MA 02139 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Talita Duarte-Salles
4Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Gran Via de les Corts Catalanes, 587, 08007 àtic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Tereza F. Abrahao
5Faculty of Medicine, University of Sao Paulo, Av. Dr. Arnaldo, 455, Cerqueira César 01246903, Sao Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heba Alghoul
6Faculty of Medicine, Islamic University of Gaza, Palestine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osaid Alser
7Massachusetts General Hospital, Harvard Medical School, Boston, 02114, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thamir M Alshammari
8Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Areia
9Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Biedermann
10Actelion Pharmaceuticals Ltd, Allschwil, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan M. Banda
11Georgia State University, 25 Park Place, Atlanta, Georgia, 30303, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan M. Banda
Edward Burn
1Centre for Statistics in Medicine. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK
4Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Gran Via de les Corts Catalanes, 587, 08007 àtic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Casajust
12Real-World Evidence, Trial Form Support, Barcelona, Spain, Consell de Cent 334-336, 08009, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristina Fišer
13University of Zagreb, School of Medicine, Andrija Štampar School of Public Health, Johna Davidsona Rockfellera 4, 10000, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill Hardin
2Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ, USA 08560
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Hester
2Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ, USA 08560
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Hripcsak
14Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
15New York-Presbyterian Hospital, 622 W 168 St, PH20 New York, NY 10032 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Skov Kaas-Hansen
16Clinical Pharmacology Unit, Zealand University Hospital, Munkesoevej 18, 4000 Roskilde, Denmark and NNF Centre for Protein Research, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sajan Khosla
17AstraZeneca, Real World Science & Digital, Cambridge CB2 1RE, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Spyros Kolovos
1Centre for Statistics in Medicine. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Spyros Kolovos
Kristine E. Lynch
18Department of Veterans Affairs, 500 Foothill Drive, Salt Lake City, UT, USA 84148
19University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT, USA 84108
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rupa Makadia
2Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ, USA 08560
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paras P. Mehta
20College of Medicine, University of Arizona, 1501 N Campbell Ave, Tucson, AZ, USA 85724
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel R. Morales
21Division of Population Health and Genomics, University of Dundee, Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Morgan-Stewart
3Real World Solutions, IQVIA, 201 Broadway # 5, Cambridge, MA 02139 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mees Mosseveld
22Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danielle Newby
23University of Oxford, Department of Psychiatry, Warneford Hospital, Oxford, OX3 7JX, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrik Nyberg
24School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg Box 463, 405 30 Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Ostropolets
14Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rae Woong Park
25Department of Biomedical Informatics, Ajou University School of Medicine, 164 World cup-ro Yeongtong-gu, Suwon-si Gyeonggi-do, 16499, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Prats-Uribe
1Centre for Statistics in Medicine. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Albert Prats-Uribe
Gowtham A. Rao
2Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ, USA 08560
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Reich
3Real World Solutions, IQVIA, 201 Broadway # 5, Cambridge, MA 02139 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Rijnbeek
22Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony G. Sena
2Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ, USA 08560
22Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azza Shoaibi
2Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ, USA 08560
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Spotnitz
14Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vignesh Subbian
26College of Engineering, University of Arizona, Tuscon, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc A. Suchard
27Departments of Biomathematics and Human Genetics David Geffen School of Medicine at UCLA, and Department of Biostatistics UCLA School of Public Health 695 Charles E. Young Dr., South Los Angeles, CA 90095 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Vizcaya
28Bayer pharmaceuticals, Av. Baix Llobregata 3-5 08970, Sant Joan Despi, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haini Wen
29Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 Huaihai West Road, Shanghai, P.R.China, 200030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel de Wilde
22Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junqing Xie
1Centre for Statistics in Medicine. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seng Chan You
25Department of Biomedical Informatics, Ajou University School of Medicine, 164 World cup-ro Yeongtong-gu, Suwon-si Gyeonggi-do, 16499, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Zhang
30School of Public Health, Peking Union Medical College, Chinese Academy of Medical Sciences Shuai Fu Yuan 1#, Dong Dan District, Beijing, P.R.China, 100730 & Melbourne School of Population and Global Health, University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lin Zhang
Simon Lovestone
2Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ, USA 08560
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Ryan
2Janssen Research and Development, 1125 Trenton Harbourton Rd., Titusville, NJ, USA 08560
14Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ryan@ohdsi.org
Daniel Prieto-Alhambra
1Centre for Statistics in Medicine. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Prieto-Alhambra
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objectives Concern has been raised in the rheumatological community regarding recent regulatory warnings that hydroxychloroquine used in the COVID-19 pandemic could cause acute psychiatric events. We aimed to study whether there is risk of incident depression, suicidal ideation, or psychosis associated with hydroxychloroquine as used for rheumatoid arthritis (RA).

Methods New user cohort study using claims and electronic medical records from 10 sources and 3 countries (Germany, UK and US). RA patients aged 18+ and initiating hydroxychloroquine were compared to those initiating sulfasalazine (active comparator) and followed up in the short (30-day) and long term (on treatment). Study outcomes included depression, suicide/suicidal ideation, and hospitalization for psychosis. Propensity score stratification and calibration using negative control outcomes were used to address confounding. Cox models were fitted to estimate database-specific calibrated hazard ratios (HR), with estimates pooled where I2<40%.

Results 918,144 and 290,383 users of hydroxychloroquine and sulfasalazine, respectively, were included. No consistent risk of psychiatric events was observed with short-term hydroxychloroquine (compared to sulfasalazine) use, with meta-analytic HRs of 0.96 [0.79-1.16] for depression, 0.94 [0.49-1.77] for suicide/suicidal ideation, and 1.03 [0.66-1.60] for psychosis. No consistent long-term risk was seen, with meta-analytic HRs 0.94 [0.71-1.26] for depression, 0.77 [0.56-1.07] for suicide/suicidal ideation, and 0.99 [0.72-1.35] for psychosis.

Conclusions Hydroxychloroquine as used to treat RA does not appear to increase the risk of depression, suicide/suicidal ideation, or psychosis compared to sulfasalazine. No effects were seen in the short or long term. Use at higher dose or for different indications needs further investigation.

TRIAL REGISTRATION Registered with EU PAS; Reference number EUPAS34497 (http://www.encepp.eu/encepp/viewResource.htm?id=34498). The full study protocol and analysis source code can be found at https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine.

WHAT IS ALREADY KNOWN ON THIS TOPIC

  • Recent regulatory warnings have raised concerns of potential psychiatric side effects of hydroxychloroquine at the doses used to treat COVID-19, generating concern in the rheumatological community

  • Serious psychiatric adverse events such as suicide, acute psychosis, and depressive episodes have been identified by the US Food and Drug Administration (FDA) adverse events reporting system and at case report level

WHAT THIS STUDY ADDS

  • This is the largest study on the neuro-psychiatric safety of hydroxychloroquine to date, including >900,000 users treated for their RA in country-level or private health care systems in Germany, the UK, and the US

  • We find no association between the use of hydroxychloroquine and the risk of depression, suicide/suicidal ideation, or severe psychosis compared to sulfasalazine

HOW MIGHT THIS IMPACT ON CLINICAL PRACTICE

  • Our data shows no association between hydroxychloroquine treatment for RA and risk of depression, suicide or psychosis compared to sulfasalazine. These findings do not support stopping or switching hydroxychloroquine treatment as used for RA due to recent concerns based on COVID-19 treated patients.

Competing Interest Statement

Miss Lane reports grants from the Medical Research Council (MR/K501256/1) and Versus Arthritis (21605), outside of the submitted work. Prof Prieto-Alhambra reports grants and other from AMGEN, grants, non-financial support and other from UCB Biopharma, grants from Les Laboratoires Servier, outside the submitted work; public-private partnerships within IMI including EHDEN and EMIF consortia and Synapse Management Partners have supported training programmes organised by DPA's department and open for external participants. Mr. Weaver, Dr. Conover, Dr. Hardin, Dr Rao, Dr. Schuemie, Mr. Sena, Dr. Shoaibi, Dr. Ryan are employees of Janssen Research and Development and shareholders of Johnson & Johnson. Dr. DuVall reports grants from Anolinx, LLC, grants from Astellas Pharma, Inc, grants from AstraZeneca Pharmaceuticals LP, grants from Boehringer Ingelheim International GmbH, grants from Celgene Corporation, grants from Eli Lilly and Company, grants from Genentech Inc., grants from Genomic Health, Inc., grants from Gilead Sciences Inc., grants from GlaxoSmithKline PLC, grants from Innocrin Pharmaceuticals Inc., grants from Janssen Pharmaceuticals, Inc., grants from Kantar Health, grants from Myriad Genetic Laboratories, Inc., grants from Novartis International AG, grants from Parexel International Corporation through the University of Utah or Western Institute for Biomedical Research, outside the submitted work. Dr. Hripcsak reports grants from US National Library of Medicine, during the conduct of the study; grants from Janssen Research, outside the submitted work; Dr. Kaas-Hansen reports grants from Innovation Fund Denmark (5153-00002B), grants from Novo Nordisk Foundation (NNF14CC0001), outside the submitted work. Dr. Khosla reports employment from AstraZeneca, outside the submitted work;Prof van der Lei, Dr de Wilde and Mr Mosseveld report grants from Innovative Medicines Initiative; Dr. Margulis reports she is an employee of RTI Health Solutions, a unit of RTI International, an independent, nonprofit research organization that does work for government agencies and pharmaceutical companies. This work was not an RTI assignment; and she participated as a citizen scientist. Dr. Morales is supported by a Wellcome Trust Clinical Research Development Fellowship (Grant 214588/Z/18/Z) and reports funding support from the NIHR, Chief Scientist Office and Tenovus Scotland for research unrelated to this work. Dr. Nyberg reports employment from AstraZeneca, outside the submitted work; Dr. Prats-Uribe reports grants from Fundacion Alfonso Martin Escudero, grants from Medical Research Council, outside the submitted work; Dr Rijnbeek reports grants from Innovative Medicines Initiative and from Janssen Research and Development, during the conduct of the study; Dr. Morgan-Stewart, Dr Torre Ms Seager and Ms Kostka are employees of IQVIA, outside of submitted work. Dr. Suchard reports grants from US National Science Foundation, grants from US National Institutes of Health, grants from IQVIA, personal fees from Janssen Research and Development, during the conduct of the study. Dr. Vizcaya is an employee of Bayer; outside submitted work. Dr. You reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study;All other authors declare no competing interests.

Clinical Trial

Registered with EU PAS; Reference number EUPAS34497 (http://www.encepp.eu/encepp/viewResource.htm?id=34498)

Clinical Protocols

https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine .

http://www.encepp.eu/encepp/viewResource.htm?id=34498

Funding Statement

A full funding statement is included in the manuscript

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

AmbEMR-This is a retrospective database study on de-identified data and is deemed not human subject research. Approval is provided for OHDSI community studies. CCAE-New England Institutional Review Board (IRB) and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research. CPRD-Approval for CPRD was provided by the Independent Scientific Advisory Committee (ISAC).This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency. The data is provided by patients and collected by the NHS as part of their care and support. The interpretation and conclusions contained in this study are those of the author/s alone. The protocol for this study ( 20_059R) was approved by the Independent Scientific Advisory Committee (ISAC). DA Germany-This is a retrospective database study on de-identified data and is deemed not human subject research. Approval is provided for OHDSI community studies. IMRD-The present study is filed and under review for Scientific Review Committee for institutional adjudication. Due to the public health imperative of information related to these data, approval is provided for this publication. IPCI-The present study was approved by the Scientific and Ethical Advisory Board of the IPCI project (project number: 4/2020). JMDC-New England Institutional Review Board (IRB) and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research. MDCD-New England Institutional Review Board (IRB) and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research. MDCD-New England Institutional Review Board (IRB) and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research. Open Claims-This is a retrospective database study on de-identified data and is deemed not human subject research. Approval is provided for OHDSI community studies. Clinformatics-New England Institutional Review Board (IRB) and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research. Optum EHR- New England Institutional Review Board (IRB) and was determined to be exempt from broad IRB approval, as this research project did not involve human subject research.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

This study was conducted as a distributed database network analysis. To protect patient privacy, all patient-level data were maintained securely behind institutional firewalls. Analysis code was downloaded and executed by each participating data partner, which generated only aggregate summary statistics (cohort counts, model coefficients) which were then centralized and synthesized in preparation of this manuscript. All aggregate summary statistics produced have been made publicly available at: https://data.ohdsi.org/Covid19EstimationHydroxychloroquine2/.

https://data.ohdsi.org/Covid19EstimationHydroxychloroquine2/.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted August 07, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study
Jennifer C.E. Lane, James Weaver, Kristin Kostka, Talita Duarte-Salles, Maria Tereza F. Abrahao, Heba Alghoul, Osaid Alser, Thamir M Alshammari, Carlos Areia, Patricia Biedermann, Juan M. Banda, Edward Burn, Paula Casajust, Kristina Fišer, Jill Hardin, Laura Hester, George Hripcsak, Benjamin Skov Kaas-Hansen, Sajan Khosla, Spyros Kolovos, Kristine E. Lynch, Rupa Makadia, Paras P. Mehta, Daniel R. Morales, Henry Morgan-Stewart, Mees Mosseveld, Danielle Newby, Fredrik Nyberg, Anna Ostropolets, Rae Woong Park, Albert Prats-Uribe, Gowtham A. Rao, Christian Reich, Peter Rijnbeek, Anthony G. Sena, Azza Shoaibi, Matthew Spotnitz, Vignesh Subbian, Marc A. Suchard, David Vizcaya, Haini Wen, Marcel de Wilde, Junqing Xie, Seng Chan You, Lin Zhang, Simon Lovestone, Patrick Ryan, Daniel Prieto-Alhambra
medRxiv 2020.07.17.20156059; doi: https://doi.org/10.1101/2020.07.17.20156059
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study
Jennifer C.E. Lane, James Weaver, Kristin Kostka, Talita Duarte-Salles, Maria Tereza F. Abrahao, Heba Alghoul, Osaid Alser, Thamir M Alshammari, Carlos Areia, Patricia Biedermann, Juan M. Banda, Edward Burn, Paula Casajust, Kristina Fišer, Jill Hardin, Laura Hester, George Hripcsak, Benjamin Skov Kaas-Hansen, Sajan Khosla, Spyros Kolovos, Kristine E. Lynch, Rupa Makadia, Paras P. Mehta, Daniel R. Morales, Henry Morgan-Stewart, Mees Mosseveld, Danielle Newby, Fredrik Nyberg, Anna Ostropolets, Rae Woong Park, Albert Prats-Uribe, Gowtham A. Rao, Christian Reich, Peter Rijnbeek, Anthony G. Sena, Azza Shoaibi, Matthew Spotnitz, Vignesh Subbian, Marc A. Suchard, David Vizcaya, Haini Wen, Marcel de Wilde, Junqing Xie, Seng Chan You, Lin Zhang, Simon Lovestone, Patrick Ryan, Daniel Prieto-Alhambra
medRxiv 2020.07.17.20156059; doi: https://doi.org/10.1101/2020.07.17.20156059

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (519)
  • Anesthesia (124)
  • Cardiovascular Medicine (1406)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (580)
  • Epidemiology (10263)
  • Forensic Medicine (6)
  • Gastroenterology (525)
  • Genetic and Genomic Medicine (2611)
  • Geriatric Medicine (253)
  • Health Economics (495)
  • Health Informatics (1727)
  • Health Policy (788)
  • Health Systems and Quality Improvement (669)
  • Hematology (266)
  • HIV/AIDS (563)
  • Infectious Diseases (except HIV/AIDS) (12066)
  • Intensive Care and Critical Care Medicine (647)
  • Medical Education (272)
  • Medical Ethics (83)
  • Nephrology (286)
  • Neurology (2448)
  • Nursing (143)
  • Nutrition (374)
  • Obstetrics and Gynecology (486)
  • Occupational and Environmental Health (565)
  • Oncology (1314)
  • Ophthalmology (397)
  • Orthopedics (145)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (341)
  • Pediatrics (776)
  • Pharmacology and Therapeutics (328)
  • Primary Care Research (294)
  • Psychiatry and Clinical Psychology (2390)
  • Public and Global Health (4987)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (520)
  • Respiratory Medicine (680)
  • Rheumatology (307)
  • Sexual and Reproductive Health (253)
  • Sports Medicine (244)
  • Surgery (296)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)